Literature DB >> 35990788

Non-alcoholic fatty liver disease (NAFLD) in Filipino North American patients: Results from a multi-ethnic cohort.

Shirley X Jiang1, Roberto Trasolini2, Michael Heer3, Benjamin Cox1, Ciaran Galts1, Vladimir Marquez2, Eric M Yoshida2.   

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is more prevalent in certain ethnicities due to a combination of genetic, environmental, and metabolic factors. North American Filipino populations may have lifestyle and metabolic risk factors for NAFLD; however, the prevalence of NAFLD in this group is unknown. We sought to determine whether Filipino patients are over-represented in a multi-ethnic NAFLD cohort and describe their clinical presentation, primarily compared to other ethnicities in the same geographical region and secondarily compared to Manila-based Filipino patients.
METHODS: A cross-sectional study was conducted with patients with NAFLD who were followed at the Hepatology Clinic at Vancouver General Hospital, Canada, from January 2015 to August 2018. Data were extracted for clinicodemographic data, ethnicity, anthropometric measures, blood work, and transient elastography (TE). External comparison data was obtained online from the Metro Vancouver census and a NAFLD study conducted in Manila, Philippines.
RESULTS: Of 317 patients meeting inclusion criteria for the study, 224 patients had complete datasets. The mean age was 51.1 years, and 50% were female. There were 139 (62%) Caucasian and other ethnicity patients, 55 (25%) Asian patients, and 30 (13%) Filipino patients. Compared to other ethnic groups, the Filipino group had similar clinical characteristics, including NAFLD fibrosis scores and TE. Of included NAFLD patients, the proportion of Filipino patients (13.39%) was significantly greater than the proportion of Filipino residents in Metro Vancouver (5.52%, p <0.01). Our Filipino Canadians seemed to be younger, with fewer females and a lower proportion of diabetes mellitus, but a higher proportion of hypertension than the previously reported cohort from Manila.
CONCLUSIONS: While Filipino patients have not previously been examined in multi-ethnic NAFLD studies, they may represent a high-risk population. Further research is needed to clarify the prevalence and presentation of NAFLD in Filipino Canadian patients, as this appears to be a significant health issue in this community.
Copyright © 2022 Canadian Association for the Study of the Liver.

Entities:  

Keywords:  Filipino; cirrhosis; ethnicity; fibrosis; non-alcoholic fatty liver disease

Year:  2022        PMID: 35990788      PMCID: PMC9231422          DOI: 10.3138/canlivj-2021-0025

Source DB:  PubMed          Journal:  Can Liver J        ISSN: 2561-4444


  28 in total

1.  Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis.

Authors:  Vincent Wai-Sun Wong; Grace Lai-Hung Wong; Angel Mei-Ling Chim; Ada Mei-Ling Tse; Steven Woon-Choy Tsang; Alex Yui Hui; Paul Cheung-Lung Choi; Anthony Wing-Hung Chan; Wing-Yee So; Francis Ka-Leung Chan; Joseph Jao-Yao Sung; Henry Lik-Yuen Chan
Journal:  Am J Gastroenterol       Date:  2008-07-04       Impact factor: 10.864

2.  Addressing the Health Needs of High-Risk Filipino Americans in the Greater Philadelphia Region.

Authors:  Aisha Bhimla; Lauren Yap; Minsun Lee; Brenda Seals; Hermie Aczon; Grace X Ma
Journal:  J Community Health       Date:  2017-04

3.  Cardiovascular risk factors among Asian Americans: results from a National Health Survey.

Authors:  Jiali Ye; George Rust; Peter Baltrus; Elvan Daniels
Journal:  Ann Epidemiol       Date:  2009-06-26       Impact factor: 3.797

4.  Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study.

Authors:  Leon A Adams; Scott Harmsen; Jennifer L St Sauver; Phunchai Charatcharoenwitthaya; Felicity B Enders; Terry Therneau; Paul Angulo
Journal:  Am J Gastroenterol       Date:  2010-02-09       Impact factor: 10.864

5.  Genetic variation I148M in patatin-like phospholipase 3 gene and risk of non-alcoholic fatty liver disease among Filipinos.

Authors:  Michael O Baclig; Jingky P Lozano-Kühne; Cynthia A Mapua; Juliet Gopez-Cervantes; Filipinas F Natividad
Journal:  Int J Clin Exp Med       Date:  2014-08-15

6.  Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.

Authors:  Jeffrey D Browning; Lidia S Szczepaniak; Robert Dobbins; Pamela Nuremberg; Jay D Horton; Jonathan C Cohen; Scott M Grundy; Helen H Hobbs
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

7.  Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.

Authors:  Zobair Younossi; Maria Stepanova; Janus P Ong; Ira M Jacobson; Elisabetta Bugianesi; Ajay Duseja; Yuichiro Eguchi; Vincent W Wong; Francesco Negro; Yusuf Yilmaz; Manuel Romero-Gomez; Jacob George; Aijaz Ahmed; Robert Wong; Issah Younossi; Mariam Ziayee; Arian Afendy
Journal:  Clin Gastroenterol Hepatol       Date:  2018-06-14       Impact factor: 11.382

8.  Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study.

Authors:  Mark G Swain; Alnoor Ramji; Keyur Patel; Giada Sebastiani; Abdel Aziz Shaheen; Edward Tam; Paul Marotta; Magdy Elkhashab; Harpreet S Bajaj; Chris Estes; Homie Razavi
Journal:  CMAJ Open       Date:  2020-06-09

9.  Non-alcoholic fatty liver disease in the Philippines: comparable with other nations?

Authors:  Mark Anthony A De Lusong; E Labio; L Daez; V Gloria
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.